In a patient with a documented codeine allergy and a patellar fracture, are morphine or hydromorphone (hydromorphine) contraindicated, and can ketorolac (Toradol) be used for pain control?

Morphine and Hydromorphone Are Safe in Codeine Allergy; Ketorolac Is Effective for Patellar Fracture Pain

Yes, you can safely give morphine or hydromorphone to a patient with codeine allergy, and yes, you can give ketorolac (Toradol) for patellar fracture pain control.

Understanding Codeine Allergy and Opioid Cross-Reactivity

Codeine is chemically distinct from morphine and hydromorphone in terms of allergic cross-reactivity. While codeine is metabolized to morphine via CYP2D6, this is a metabolic pathway—not a structural similarity that causes allergic cross-reactivity 1.

Critically, hydromorphone causes little or no histamine release and may be safely administered to patients who report a type 2 allergy to morphine (urticaria, pruritus, and facial flushing) 2. Recent evidence demonstrates 100% re-exposure tolerance rates across different opioid classes in patients with previously documented opioid allergies or adverse drug reactions, with no cross-reactivity found among natural, semisynthetic, and synthetic opioid classes 3.

Practical Algorithm for Opioid Selection:

1. If true IgE-mediated allergy to codeine (rare): Use morphine or hydromorphone—these are structurally different enough to avoid cross-reactivity
2. If histamine-mediated reaction to morphine (urticaria, flushing): Use hydromorphone preferentially 2
3. If codeine "allergy" is actually intolerance (nausea, constipation): Any opioid is safe; choose based on efficacy

Opioid Recommendations for Patellar Fracture

For acute severe pain from patellar fracture, hydromorphone (0.015 mg/kg IV) is recommended as comparable and potentially superior to morphine (0.1 mg/kg IV) 2. The advantages include:

• Quicker onset of action compared to morphine
• More potent at smaller milligram doses (physicians more likely to adequately treat pain with 1.5 mg hydromorphone vs. 10 mg morphine)
• Lower risk of dose stacking and subsequent respiratory depression
• Minimal histamine release 2

For IV administration, start with 0.2-1 mg hydromorphone every 2-3 hours, given slowly over at least 2-3 minutes 4.

Ketorolac (Toradol) for Patellar Fracture

Yes, ketorolac is highly effective and safe for patellar fracture pain. NSAIDs are recommended over codeine-acetaminophen combinations for acute musculoskeletal pain 2, 5.

Evidence Supporting Ketorolac Use:

• Efficacy: Ketorolac provides comparable analgesia to morphine for orthopedic fracture pain 6, 7
• Opioid-sparing: Reduces opioid consumption by approximately 30-40% in fracture patients 8, 9
• Bone healing safety: Multiple studies show no increased risk of nonunion or delayed union with short-term perioperative ketorolac use in fractures, including ankle fractures (94% healed by 12 weeks), femoral fractures (0.8% nonunion rate), and scaphoid fractures 10, 11, 8, 9, 12

Critical Caveats for Ketorolac:

• Duration matters: Animal studies show dose-dependent delayed union risk only with high doses for ≥4 weeks; 7-day courses show no risk 10
• Avoid in spine surgery: Increased pseudoarthrosis risk documented in spine fusion procedures 10
• Standard contraindications apply: Avoid in renal insufficiency, GI bleeding risk, anticoagulation

Practical Dosing for Patellar Fracture:

Multimodal approach combining both:

• Ketorolac 10-15 mg IV/IM every 6 hours (maximum 5 days)
• Plus hydromorphone 0.5-1 mg IV every 2-3 hours as needed for breakthrough pain
• This combination provides superior analgesia while minimizing opioid requirements 5, 8

Common Pitfall to Avoid

The most common error is avoiding all opioids in patients with documented "codeine allergy" when the reaction was likely a side effect (nausea, constipation) rather than true allergy. True IgE-mediated opioid allergies are exceedingly rare 3. Most documented "allergies" are actually:

• Predictable side effects (nausea, constipation, sedation)
• Histamine-mediated reactions (flushing, itching—not true allergy)
• CYP2D6 polymorphism effects (poor metabolizers get no analgesia; ultra-rapid metabolizers get toxicity) 1

Document the specific reaction type to guide future prescribing rather than blanket avoidance of all opioids.